COPS5 Triggers Ferroptosis Defense by Stabilizing MK2 in Hepatocellular Carcinoma
Authors:
Open Access
- 8 April 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (22) , e2416360
Abstract
Sorafenib, which is proven to serve as a potent ferroptosis inducer, is used as a first‐line treatment for patients with advanced hepatocellular carcinoma (HCC), but it has limited clinical benefits, mainly due to drug resistance. Herein, using genome‐wide CRISPR/Cas9 knockout screening and multiple functional studies, this work identifies COP9 signalosome subunit 5 (COPS5) as a driver of sorafenib resistance and a suppressor of ferroptosis in HCC. Consistently, the amplification and overexpression of COPS5 are frequently observed in clinical HCC samples, which are associated with poor patient prognosis and might predict patient response to sorafenib therapy. Mechanistically, COPS5 stabilized mitogen‐activated protein kinase 2 (MK2) through deubiquitination and, in turn, induced the activation of heat shock protein beta‐1 (HSPB1), a ferroptosis repressor, thereby protecting HCC cells from ferroptosis and consequently leading to sorafenib resistance and tumor progression, while its own expression could be induced by sorafenib treatment via activating transcription factor 4 (ATF4)‐activated transcription. Furthermore, pharmacological inhibition of COPS5/MK2 synergize with sorafenib to induce ferroptosis and suppress HCC progression. This data reveals the crucial role of COPS5 in triggering ferroptosis defense and sorafenib resistance through the activation of the MK2‐HSPB1 axis in HCC and highlights the potential of targeting COPS5/MK2 combined with sorafenib as a promising strategy for treating HCC.Keywords
Funding Information
- National Natural Science Foundation of China (82173062, 82473968)
- Natural Science Foundation of Guangdong Province (2024A1515013082)
- Guangzhou Medical University (176)
- Bureau of Education of Guangzhou Municipality (202235387)
- Guangzhou Municipal Science and Technology Bureau (2024A03J0550, 2023A03J0428)
- Department of Education of Guangdong Province (2021ZDZX2017)
This publication has 70 references indexed in Scilit:
- Jab1/Cops5: a promising target for cancer diagnosis and therapyInternational Journal of Clinical Oncology, 2021
- Jab1 promotes gastric cancer tumorigenesis via non-ubiquitin proteasomal degradation of p14ARFGastric Cancer, 2020
- CSN5/Jab1 facilitates non-small cell lung cancer cell growth through stabilizing survivinBiochemical and Biophysical Research Communications, 2018
- The emerging roles of Jab1/CSN5 in cancerMedical Oncology, 2016
- Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosisHepatology, 2016
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015
- Down‐regulation of the cyclin‐dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesisHepatology, 2015
- Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinomaHepatology, 2013
- Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathologyCellular and Molecular Life Sciences, 2009
- Roles for CSN5 in control of p53/MDM2 activitiesJournal of Cellular Biochemistry, 2007